Michael Forbes, CEO of Adastra, claimed in his Preliminary press release: “Hurt reduction is actually a critically critical and mainstream matter, and we're keeping on the forefront of drug regulations through the board.” The corporate didn’t include that detail in its Original press launch, which reported Adastra has become certified to d